|1.||Itoh, Kyogo: 10 articles (10/2015 - 10/2006)|
|2.||Noguchi, Masanori: 7 articles (10/2015 - 06/2007)|
|3.||Yamada, Akira: 6 articles (10/2015 - 06/2005)|
|4.||Slansky, Jill E: 6 articles (11/2013 - 01/2008)|
|5.||Celis, Esteban: 5 articles (08/2015 - 04/2002)|
|6.||Jordan, Kimberly R: 5 articles (11/2013 - 01/2008)|
|7.||Kaumaya, Pravin T P: 5 articles (07/2013 - 04/2003)|
|8.||Sin, Jeong-Im: 5 articles (04/2013 - 05/2006)|
|9.||Sasada, Tetsuro: 4 articles (10/2015 - 01/2013)|
|10.||Slingluff, Craig L: 4 articles (11/2014 - 04/2006)|
06/01/2014 - "Overall, this study demonstrates that eliciting CD4 T cell responses against components of the Salmonella type III secretion system can contribute to protection against infection and should be considered in the design of future Salmonella subunit vaccines. "
11/01/2006 - "Recent clinical trials in young women have shown that subunit vaccines based on human papillomavirus (HPV) 16 and HPV18 L1 virus-like particles are approximately 100% effective in short-term prevention of persistent cervical infection and of cervical dysplasia by these major oncogenic types. "
01/01/2015 - "Peptide vaccines have been shown effective in preventing animal infection in some instances, and various formulations are under evaluation for their potential clinical use in humans. "
01/01/1999 - "Synthetic peptide vaccines effective in preventing virus infection."
01/01/2015 - "Recombinant subunit vaccines provide safe and targeted protection against viral infections. "
08/01/2007 - "Radiation plus E7 subunit vaccines improved complete response, cure, and recurrence rates of tumors dramatically compared with single therapy alone. "
08/01/2014 - "ErbB-2-directed peptide vaccines have been shown to be effective in prevention of spontaneous tumorigenesis of breast in neu transgenic mouse model, and cellular immunity is proposed as a mechanism for the anti-tumor efficacy. "
01/01/2014 - "Novel adjuvants hold the promise for developing effective modern subunit vaccines capable of appropriately modulating the immune response against challenging diseases such as those caused by chronic and/or intracellular pathogens and cancer. "
04/28/2013 - "Peptide vaccines are a clinically applicable therapy shown to be effective in tumor control. "
07/01/2007 - "Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo."
03/01/2013 - "Protection against malaria can be achieved by induction of a strong CD8(+) T-cell response against the Plasmodium circumsporozoite protein (CSP), but most subunit vaccines suffer from insufficient memory responses. "
12/01/2002 - "It is widely believed that subunit vaccines composed of multiple components will offer greater protection against challenge by malaria, and yet there is little experimental evidence to support this view. "
12/01/2005 - "However, the limited complexity of malaria peptide vaccines raises questions regarding their equivalence to immune responses elicited by the irradiated sporozoite vaccine, the "gold standard" for protective immunity. "
06/16/2011 - "While subunit vaccines have shown partial efficacy in clinical trials, radiation-attenuated sporozoites (RAS) remain the "gold standard" for sterilizing protection against Plasmodium infection in human vaccinees. "
01/01/2010 - "Over the past decade (2000-2009), there have been nine clinical trials of synthetic malaria peptide vaccines designed to target the pre-erythrocytic and erythrocytic stages of the Plasmodium falciparum parasite. "
|4.||Human Influenza (Influenza)
03/01/2013 - "The increased worldwide awareness of seasonal and pandemic influenza, including pandemic H1N1 virus, has stimulated interest in the development of economic platforms for rapid, large-scale production of safe and effective subunit vaccines. "
01/01/2012 - "These results demonstrate the promising potential of microneedle delivery of licensed influenza subunit vaccines, that could be beneficial in increasing vaccine coverage and protection and reducing influenza-related mortality worldwide."
03/05/1999 - "The aim of this study was to improve the potency of the currently used influenza subunit vaccines, which are of relatively low efficiency in high-risk groups. "
04/01/2015 - "Influenza whole inactivated virus (WIV) is more immunogenic and induces protective antibody responses compared with other formulations, like split virus or subunit vaccines, after intranasal mucosal delivery. "
01/01/2014 - "Recombinant subunit vaccines are an efficient strategy to meet the demands of a possible influenza pandemic, because of rapid and scalable production. "
11/01/1995 - "Tuberculosis remains a major public health burden which could be ameliorated by effective and well-defined subunit vaccines, particularly because the protective efficacy of current M. "
01/01/2009 - "tuberculosis, improved recombinant BCG strains and subunit vaccines have been tested in preclinical animal models, and some of them showed promising results. "
11/11/2008 - "Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c)."
05/01/2014 - "In order to ensure an ample supply of quality candidate tuberculosis (TB) subunit vaccines for clinical trials, it is imperative to develop new immunostimulatory adjuvants. "
06/01/2009 - "These studies have major implications for the design of sulfoglycolipid analogs with potential use as tuberculosis subunit vaccines."
|2.||DNA (Deoxyribonucleic Acid)
|7.||Recombinant DNA (Recombinant DNA Research)
|9.||Proteins (Proteins, Gene)
|10.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|2.||Drug Therapy (Chemotherapy)